Hair Loss Prevention Study for Pancreatic Cancer
NCT: NCT04492800 · COMPLETED
NCT IDNCT04492800
StatusCOMPLETED
Start Date2019-12-13
Completion2021-12-31
Brief Summary
Pilot study intended for hair loss prevention in patients with pancreatic cancer who are receiving treatment containing nab-paclitaxel, gemcitabine and cisplatin.
Frequently Asked Questions
What is Hair Loss Prevention Study for Pancreatic Cancer?
Hair Loss Prevention Study for Pancreatic Cancer is a clinical trial registered under NCT04492800. Current status: COMPLETED.
What is the status of NCT04492800?
The current status of NCT04492800 (Hair Loss Prevention Study for Pancreatic Cancer) is: COMPLETED.
When did Hair Loss Prevention Study for Pancreatic Cancer start?
Hair Loss Prevention Study for Pancreatic Cancer started on 2019-12-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.